California’s Stem Cell Agency’s New Strategic Plan Outlines Vision for the Future
Creative partnerships to move promising stem cell therapies into clinical trials; a pioneering new kind of clinic to help deliver those therapies to patients; and a renewed commitment to delivering health and economic benefits to California - those are some of the key elements in the new Strategic... - June 09, 2012
Michael Marletta Appointed to Governing Board of California’s Stem Cell Agency
Michael A. Marletta, PhD, President and CEO of The Scripps Research Institute, has been appointed to the Independent Citizens Oversight Committee (ICOC), the governing board of California’s stem cell agency, the California Institute for Regenerative Medicine (CIRM). “California has led... - May 20, 2012
Stem Cell Agency Unveils Strategic Partnership Fund to Increase Investment and Engagement with Industry in Stem Cell Therapies for Patients
The state’s stem cell agency, the California Institute for Regenerative Medicine (CIRM) is committing up to $30 million to a Strategic Partnership Awards Initiative to attract industry engagement and investment in CIRM-funded stem cell research. - April 19, 2012